Shardul Nautiyal, Mumbai
July 03, 2018
:
In order to implement the new Medical Device (MD) Rules, the Gujarat Food and Drug Control Administration (FDCA) has notified 145 MD officers to inspect Class A and Class B medical device
Laxmi Yadav, Mumbai
July 03, 2018
:
Stepping up efforts to check illegal manufacturing and import of oxytocin in the country, the Central Drugs Standard Control Organisation (CDSCO) along with Bihar drugs control administration has raided 35 manufacturing units at Gaya and Bodh Gaya
Arun Sreenivasan, NEW DELHI
July 02, 2018
:
The Department of Pharmaceuticals (DoP) will rope in a third-party project management consultant (PMC) to execute the proposed pharmaceutical cluster development programme to be implemented on a public-private partnership (PPP) format.
Shardul Nautiyal, Mumbai
July 02, 2018
:
Equipped to handle and test multiple samples in two hours time, Gujarat Food and Drug Control Administration (FDCA) is all set to create a benchmark in terms of testing and analysis of contamination of pharmaceutical products
A Raju, Hyderabad
July 02, 2018
:
The Andhra Pradesh Drug Control Administration (APDCA) authorities, with an aim to create awareness among the general public about low prices of generic drugs fixed by the National Pharmaceutical Pricing Authority’s (NPPA)
Arun Sreenivasan, New Delhi
July 02, 2018
:
The Department of Pharmaceuticals (DoP) has turned down a review petition filed by Sun Pharma Laboratories against the ceiling price fixed by the National Pharmaceuticals Pricing Authority (NPPA) for its Amphotericin B Liposomal 50mg injection.
Shardul Nautiyal, Mumbai
June 30, 2018
:
The Gujarat Food and Drug Control Administration (FDCA) has approved layout designs of 150 pharmaceutical companies including the major ones being of American medical technology provider Abbott, Israel
Arun Sreenivasan, New Delhi
June 29, 2018
:
A Drugs Technical Advisory Board (DTAB) sub-committee reviewing the ban on 349 fixed dose combination (FDC) drugs has completed hearings of petitioners and appellants and is expected to submit its final report
Shardul Nautiyal, Mumbai
June 27, 2018
:
The Maharashtra FDA will soon start risk based inspections to check the compliance levels for good manufacturing practices (GMPs) following responses of self-audit from around 800 manufacturers in the state.
Arun Sreenivasan, New Delhi
June 26, 2018
:
Facing criticism over its failure to create a favourable environment for the domestic bulk drug industry while foreign countries queue up with incentive-laced offers to woo Indian firms, the government has come up